Denison Mines Corp. (NYSEAMEX: DNN) closed Monday with an incline of 8.85% to a market valuation of $1.23 per share, after the company announced the closing of its previously announced transaction whereby Energy Fuels Inc. ("Energy Fuels") will acquire all of the shares of the subsidiaries holding Denison's U.S. mining assets and operations (the "US Mining Division"), as well as all of the inter-company debt between Denison and the US Mining Division (the "Transaction"). Volume rose to 1.19M, bypassing its average of 579,197.00 shares for the day. DNN has an RSI of 31.99, indicating a highly oversold level for the company.
DO NOT BUY OR SELL DNN UNTIL YOU READ THIS FREE TREND ANALYSIS REPORT: http://www.hotstockprofits.com/stockquotes/?q=DNN
Stereotaxis Inc. (NASDAQ: STXS) lost 6.19% to $0.197 per share following news that The Nasdaq Stock Market notified Stereotaxis Inc. that it was in danger of being delisted because it did not maintain a market value of publicly held shares of $15 million for the 30 previous business days, according to a regulatory document filed Friday with the U.S. Securities and Exchange Commission. Volume closed at a high of 3.00M, its average being left behind at 509,812.00 shares. Market capitalization closed at 11.11M as well. RSI for the company resided at 35.59, indicating an oversold level for the company.
DO NOT BUY OR SELL STXS UNTIL YOU READ THIS FREE TREND ANALYSIS REPORT: http://www.hotstockprofits.com/stockquotes/?q=STXS
Corcept Therapeutics Incorporated (NASDAQ: CORT) closed Monday with a deficit of 4.68% to $4.28 per share following the announcement that it is offering to issue and sell 11,000,000 shares of its common stock in an underwritten public offering. Credit Suisse Securities (USA) LLC is acting as sole book-running manager and underwriter in the offering. Volume surged to 1.40M, bypassing its average of 393,140.00 shares for the day. CORT’s MACD has taken a slight downturn, indicating a decreased cash flow towards the company’s equity.
DO NOT BUY OR SELL CORT UNTIL YOU READ THIS FREE TREND ANALYSIS REPORT: http://www.hotstockprofits.com/stockquotes/?q=CORT
NeurogesX, Inc. (OTC: NGSX) plummeted 31.7% to $0.205 per share after the company revealed that it has been notified by The NASDAQ Stock Market (NASDAQ) that trading in the Company's securities will be suspended on NASDAQ effective with the open of trading on Friday, June 29, 2012. On that same date, the Company's common stock will be eligible to trade on the Over the Counter Bulletin Board (OTCBB), a market tier for OTC-traded companies that are registered and current in their reporting obligations with the Securities and Exchange Commission. Volume skyrocketed to 146,533.00, its average being 43,479.00. Market capitalization for the company closed at 6.80M as well.
DO NOT BUY OR SELL NGSX UNTIL YOU READ THIS FREE TREND ANALYSIS REPORT: http://www.hotstockprofits.com/stockquotes/?q=NGSX
HotStockProfits.com is owned and operated by ALG Financial, a full-service financial communications and investor relations firm. HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
Subscribe to the FREE e-newsletter: www.HotStockProfits.com
Disclosure: HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here